🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aortic stenosis (AS) is the most frequent valvulopathy in Western countries...
Status
Completed
Location
Brest University Hospital
Start Date
2022-10-26
Trial ID
NCT05237804
Treatments Being Tested
This study is to evaluate the prevalence, plaque characteristics (plaque ty...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2006-07
Trial ID
NCT01850693
Although there are numerous studies that have demonstrated the impact of sy...
Status
Unknown
Location
Cardio Med Medical Center
Start Date
2022-08-05
Trial ID
NCT05488249
Treatments Being Tested
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and...
Status
Recruiting
Location
Amsterdam UMC
Start Date
2023-01-25
Trial ID
NCT06519292
The study is designed to evaluate the predictive diagnostic accuracy of Son...
Status
Completed
Location
North Shore University Hospital
Start Date
2010-01
Trial ID
NCT01040923
Treatments Being Tested
Background: The prevalence of heart failure (HF) is rapidly rising in indus...
Status
Completed
Location
University of Calgary
Start Date
2011-02
Trial ID
NCT01283659
Treatments Being Tested
The primary design of this study is an ambispective cohort study. We plan t...
Status
Not Yet Recruiting
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2026-01-01
Trial ID
NCT07353762
The purpose of this study is to determine whether fluorescence angiography ...
Status
Terminated
Location
University Hospital of Grenoble
Start Date
2012-08
Trial ID
NCT01681797
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713